Bridgefront Capital, LLC Abbott Laboratories Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $213,950 - $238,822	2,124 New	2,124 $220,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $921,673 - $1.11 Million	9,648 New	9,648 $934,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $646,763 - $715,508	-5,544 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $586,499 - $690,394	5,544 New	5,544 $643,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.